Filter by: Subject

Filter by: Subject

Results Per Page:

SDG-03: Good health and well-being (23)
Alternative splicing (11)
Low- and middle-income countries (LMICs) (8)
Human immunodeficiency virus (HIV) (7)
Human papillomavirus (HPV) (6)
South Africa (SA) (6)
Biomarkers (5)
Prostate cancer (5)
Angiogenesis (4)
Breast cancer (4)
Cancer (4)
Drug resistance (4)
Lung cancer (4)
Precision medicine (4)
Precision oncology (4)
Therapeutic targets (4)
Cell cycle (3)
Cervical cancer (3)
Colorectal cancer (CRC) (3)
Coronavirus disease 2019 (COVID-19) (3)
COVID-19 pandemic (3)
Lopinavir/ritonavir (LPV/r) (3)
Metabolites (3)
Metastasis (3)
Non-AIDS defining cancers (NADCs) (3)
Obesity (3)
Sub-Saharan Africa (SSA) (3)
Treatment (3)
Aberrant splicing (2)
Acquired immune deficiency syndrome (AIDS) (2)
Adenocarcinoma (2)
Africa (2)
Antiretroviral therapy (ART) (2)
Artificial intelligence (AI) (2)
Bioinformatics (2)
Brazil (2)
Carcinogenesis (2)
Cell cycle regulation (2)
Competing endogenous RNAs (ceRNAs) (2)
Diagnosis (2)
Differential gene expression (2)
DNA damage response (DDR) (2)
Domain with no name (DWNN) (2)
Efavirenz (EFV) (2)
Epigenetic modifications (2)
Gastric cancer (2)
Green nanotechnology (2)
Health sciences article SDG-03 (2)
Highly active antiretroviral therapy (HAART) (2)
Immunosuppression (2)
India (2)
Ingenuity pathway analysis (IPA) (2)
Machine learning (2)
Microbiome (2)
Microbiota (2)
MicroRNA (miRNA) (2)
MicroRNAs (miRNAs) (2)
Neurogenesis (2)
Next-generation sequencing (NGS) (2)
Oesophageal cancer (2)
p53 (2)
Patients (2)
Phytomedicine (2)
Prostate cancer (PCa) (2)
Retinoblastoma binding protein 6 (RBBP6) (2)
Ribonucleic acid (RNA) (2)
South Africa (2)
Splice variants (2)
SR proteins (2)
Tanzania (2)
Venous thromboembolism (VTE) (2)
2,2 Diphenyl-1-picryl hydrazyl (DPPH) (1)
A549 cells (1)
Aberrant splicing events (1)
Absorption, distribution, metabolism, and excretion (ADME) (1)
Acute myeloid leukaemia (AML) (1)
Acute myeloid leukemia (AML) (1)
Adipose tissue (1)
African norms (1)
African population (1)